Dale Sanders, Chief Technology Officer at Health Catalyst, Inc. (HCAT), sold 27,500 shares at $28.82 ($795K) on 2020-07-01, disclosed to the SEC on 2020-07-06.
Open-market sale of $795k HCAT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.82 | 24,700 | $712K | 89.5% |
| 2 | $29.79 | 2,800 | $83K | 10.5% |
| Total | $28.92 avg | 27,500 | $795K | 100% |
| Filing → |
| HCAT | SELL | 2020-06-03 | $742K | — | Filing → |
| HCAT | SELL | 2020-05-05 | $698K | — | Filing → |
| HCAT | SELL | 2020-04-03 | $1.4M | — | Filing → |